Elsubrutinib,Upadacitinib,ABBV-599
AbbVie
['upadacitinib', 'rinvoq', 'sleek', 'lupus', 'abbvie']
abbvie presents p-ii study (sleek) results of rinvoq (upadacitinib) for the treatment of systemic lupus erythematosus at eular 2023 #clinicaltrials 
Real-time summarized News in 3 shots from pharma, biotech, medtech, digital health and life sciences industry readable in 60 seconds